EICHORCondition: Prostate Cancer · Sponsor: University Hospital Schleswig-Holstein
Interested? Contact the study team ↓
Sponsor, CRO or site team? See where this study is running → — listed sites, countries and recruiting context. Everything below is written for patients and caregivers.
Hypofractionated radiosurgery with 5 fractions is considered standard of care for localized prostate cancer. The investigators initiated this multicenter phase II prospective trial to analyse feasibility (toxicity) of hypofractionated radiosurgery with 3 fractions in patients with localised prostate cancer under the hypothesis that the ratio of patients with late GU and GI toxicity ≥ grade 2 after 1 year amounts to 8.4% and 1.3% and is significant lower than 16.4% and 5.7% currently.
This description comes directly from the study's public registry record.
Oliver Blanck, PhD · +4943150026666 · oliver.blanck@uksh.de
Frauke Walther-Clausnizer · +4943150026581 · Frauke.Walther-Clausnizer@uksh.de
There is no obligation to join — the study team can answer your questions about taking part.
Always discuss trial participation with your own doctor first.
Inclusion Criteria: * Localised, histopathologically confirmed Prostate Cancer (cT1-T2c N0 M0) * Gleason-grade ≤7, ISUP Grade Group 1-3 * Guideline-based staging * Age ≥ 18 years * PSA \< 20 ng/ml * Volume of the prostate \< 80 cm³ * IPSS-Score ≤ 12 * Written informed consent Exclusion Criteria: * History of prior pelvic radiotherapy * Previous transurethral resection, laser enucleation or prostate ablation * Contraindication to MRI or Fiducial marker implantation (e.g. gold allergy) * Relevant comorbidity thought to adversely affect treatment compliance * Legal incapacity or lack of informed consent
Reproduced word-for-word from the public registry record — the study team can answer questions about it.
| Saphir Radiosurgery Center Frankfurt am Main | Frankfurt am Main, Hesse, Germany | Recruiting |
| University Hospital Frankfurt | Frankfurt am Main, Hesse, Germany | Suspended |
| European Radiosurgery Center Munich | Munich, Hesse, Germany | Recruiting |
| Saphir Radiosurgery Center Norther Germany | Kiel, Schleswig-Holstein, Germany | Active Not Recruiting |
| University Medical Center Schleswig-Holstein | Kiel, Schleswig-Holstein, Germany | Recruiting |
| CyberKnife Centrum Mitteldeutschland | Erfurt, Thuringia, Germany | Recruiting |
This study lists sites in the areas below. Each link shows other recruiting studies near that city, from the public registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06914544